Replies to post #112704 on Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

It was from a trusted source on another message board. I couldn’t share the email because it’s a violation on iHub. You guys can take it for what it’s worth. I don’t have any agenda here.

When did that happen? Why is everyone left to guess qualifying price if it was already a known given?

[TOB]

The actual quote was:

Leo indicated in an email to me the price for up listing has to be at or near $4.00.

As there is no listing standard requirement of "at or near", this supports my view that CTIX qualified under the $2 closing price alternative, however, NASDAQ is using their discretion on when to approve. It appears they want a rising share price.

Alternatively, if it is after the 10-K, I expect CTIX will qualify under the $3 closing price alternative as well, and hopefully counting days towards completing 90 day bid price of $4 as well.

But I'm just guessing. It could happen sooner, but I do believe it is inevitable at this point. CTIX NASDAQ is when, not if.

IMO it is a mistake to create a false expectation based upon $3 for 5 days as we just don't know. Similar to the expectation of the timing of the corporate update, that was an estimated time-frame, not a "promise". Yet we did indeed get the Brilacidin P3 approval update in that time-frame.

These expectations and opinions tend to become message board "facts" and then unnecessary disappointments when the real facts have a different time-frame.

Bottom line for me: With Brilacidin P3 approved, and two active P2 and one P1 clinical trial with another P2 trial in the wings, CTIX is doing great. The share price will catch up to these actual FACTS when it does. (Consult your tea leaves or favourite fortune teller for this exact timing. Fortune teller TOB says: CTIX is deeply undervalued and will correct to the up-side. Only patience is required)